The brief highlights a straightforward amino acid supplement that appears to lessen neuropathological processes linked to Alzheimer's disease in preclinical models. For mental health professionals, the relevance lies in the potential connections between neurodegenerative pathology and cognitive-behavioral outcomes, as well as the possibility of approachable, low-cost interventions that may influence brain inflammation and protein aggregation. This content may prompt reflection on how emerging translational research could inform future integrative care approaches for clients at risk of cognitive decline or mood changes associated with neurodegenerative processes.

Article Title: This simple amino acid supplement greatly reduces Alzheimer’s damage

Link to Science Daily Mind-Brain News: https://nolinkpreview.com/www.sciencedaily.com/releases/2026/05/260504075512.htm

#alzheimers #arginine #neuroinflammation #amyloid #cognitivehealth #neuroscience #aging #mentalhealth #research #mindbrain

New book coming out in the Methods in Enzymology series, on Structural studies of #amyloid beta: www.sciencedirect.com/bookseries/m... Edited by Rob Tycko (NIH) and Wei Qiang (Binghamton University). With a range of topics included, from experimental to computational.

Methods in Enzymology | Volume...

This note highlights a shift in the evidence base for dementia interventions, underscoring the need for cautious interpretation of treatment benefits and risks. For mental health professionals, the finding that amyloid-clearing therapies may offer little patient-level improvement while elevating brain risk informs discussions about treatment expectations, monitoring, and shared decision-making with clients and families. It also reinforces the importance of considering adverse effects and the overall risk–benefit balance when evaluating pharmacological options within neurodegenerative care.

Article Title: Alzheimer’s drugs may not work and could raise brain risks

Link to Science Daily Mind-Brain News: https://nolinkpreview.com/www.sciencedaily.com/releases/2026/05/260502233915.htm

#alzheimers #amyloid #neurodegeneration #brainhealth #clinicaltrials #treatmentrisks #drugtherapy #neuropsychology #mindbrainnews #shareddecisionmaking

#Alzheimer? vergisses!

Das will keiner wissen ... der daran verdient:
https://arstechnica.com/science/2026/04/whats-the-deal-with-alzheimers-disease-and-amyloid/?utm_brand=arstechnica&utm_social-type=owned&utm_source=mastodon&utm_medium=social

The #Amyloid #Mafia
“You were just lucky when you weren’t beaten up by the amyloid-β or tau people if you would mention #immunology,” said Michael Heneka, a neuroinflammation specialist interviewed by Nature in 2023.

What’s the deal with Alzheimer’s disease and amyloid?

For decades, scientists have concentrated on what now looks to be a blind alley.

Ars Technica

Bart De Strooper presented at the Copenhagen AD/PD-conference an excellent sketch of the three main inflection points in the pathophysiological evolution of Alzheimer's disease, https://www.alzforum.org/news/conference-coverage/big-picture-three-inflection-points-mark-amyloid-cascade

My own transition from amyloid plagues to p-tau and tangles was retarded by a four years' anti-amyloid therapy in a clinical reaearch project during 2017-22 (aducanumab). Sadly, the most probable explanation for my rapidly worsening cognitive problems may indeed be the tau-tangles, which I somehow avoided earlier. I know there are experimental therapies around somewhere for those gremlins too, but sadly not within my own reach. With respect to my AD, I'm afraid, it's "too late, my friend".

I encourage anybody with a slowly lethal disease to keep mentally in touch with it as long as you can. That's what we human beings were made for. 🤗

#alzheimer #ad #at #disease #medical #amyloid #tau #lethal #sairaus #alzForum #realism #humanity #reflection #thinking #dying #terminallyill #metacognition #tietoisuus #consciousness

AIns (insulin) type amyloidosis in a kidney transplant candidate with a newly identified monoclonal gammopathy - PubMed

Proteomics-based amyloid typing allows sensitive and specific identification of both common and rare amyloid types. Amyloid typing by this method ensures appropriate clinical management of patients with both systemic and localized amyloidosis.

PubMed

This brief highlights a mechanistic advance with implications for understanding neurodegenerative processes and potential avenues for intervention. For mental health professionals, the relevance lies in how shifts in amyloid handling and related neural signaling may relate to cognitive trajectories and mood changes observed in aging populations, informing holistic considerations in assessment and care planning.

Article Title: Scientists discover brain switches that clear Alzheimer’s plaques

Link to Science Daily Mind-Brain News: https://ift dot tt/lPD2KS7

Researchers have identified two brain receptors that help the brain clear away amyloid beta, a hallmark of Alzheimer’s disease. By stimulating these receptors in mice, scientists increased levels of a natural amyloid-breaking enzyme, reduced buildup in the brain, and improved memory-related behavior. Because these receptors are common drug targets, the findings could open the door to affordable pill-based treatments with fewer side effects.

via Mind & Brain News -- ScienceDaily https://ift dot tt/VXOkh6S

February 17, 2026 at 05:30AM

#alzheimers #amyloid #neuroscience #brainhealth #neurodegeneration

Copy and paste broken link above into your browser and replace "dot" with "." for link to work.

We have to do it this way to avoid display of copyrighted images.

Notable for mental health professionals, including psychotherapists, counselors, and social workers, the article highlights two key points: (1) neurons actively respond to amyloid beta and inflammatory cues via a shared receptor, triggering synapse loss; (2) targeting this receptor could offer protective strategies for memory beyond current amyloid-focused therapies.

Article Title: Alzheimer’s may trick the brain into erasing its own memories

Link to Science Daily Mind-Brain News: https://ift dot tt/N2fhAIS

#Alzheimers #MemoryLoss #SynapsePruning #Neuroinflammation #Amyloid

Copy and paste broken link above into your browser and replace "dot" with "." for link to work.

阿茲海默症有害蛋白質 新療法可在數小時內清除 實驗成功逆轉小鼠腦退化
由西班牙卡塔隆尼亞生物工學研究所 (IBEC) 與中國四川大學華西醫院組成的國際研究團隊,開發出創新阿茲海默症 […]
#健康 #生活科技 #Alzheimer #Amyloid beta
https://unwire.hk/2025/10/17/alzheimers-nanoparticle-clears-amyloid-beta-hours/life-tech/health/?utm_source=rss&utm_medium=rss&utm_campaign=alzheimers-nanoparticle-clears-amyloid-beta-hours